title: Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice.
abstract: In view of the current interest in the use of lymphoid cells in adoptive immunotherapy of patients with advanced cancer, we have studied the homing patterns of various lymphoid effector cells in mammary-tumor-bearing mice. Single-cell suspensions of total splenocytes, natural killer (NK) cells, and lymphokine-activated killer (LAK) cells were prepared from the spleens of C3H/OuJ mice. Tumor-infiltrating lymphocytes (TIL) were isolated from mammary adenocarcinomas excised from retired breeder females of the same substrain. Effector cells were labeled with indium-111 and injected via a tail vein into female C3H/OuJ mice bearing one or more mammary tumors. Twenty-four hours after administration, total splenocytes, NK cells, and LAK cells distributed themselves evenly between normal mammary tissue and mammary adenocarcinomas. Only TIL had a higher concentration in tumors than in corresponding normal mammary tissue. The ability of the different lymphocyte preparations to lyse YAC-1 cells was determined by means of a 4-h 51Cr-release cytotoxicity assay. Cells harvested from LAK cell cultures and further enriched by centrifugation through a discontinuous Percoll gradient and interleukin-2 (IL-2)-stimulated TIL demonstrated the highest levels of cytotoxicity, while total splenocytes and fresh TIL were characterized by the lowest levels. Since IL-2-stimulated TIL were highly cytotoxic and exhibited better tumor localization than both NK cells and LAK cells in this system, they may be the lymphoid effectors of choice for adoptive immunotherapy of advanced cancer.
authors.affiliation: Department of Anatomy, State University of New York, Syracuse 13210.
authors.forename: I H
authors.initials: IH
authors.lastname: Ames
authors.forename: G M
authors.initials: GM
authors.lastname: Gagne
authors.forename: A M
authors.initials: AM
authors.lastname: Garcia
authors.forename: P A
authors.initials: PA
authors.lastname: John
authors.forename: G M
authors.initials: GM
authors.lastname: Scatorchia
authors.forename: R H
authors.initials: RH
authors.lastname: Tomar
authors.forename: J G
authors.initials: JG
authors.lastname: McAfee
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology*; D000818:Animals; D002465:Cell Movement; D003602:Cytotoxicity, Immunologic; D005260:Female; D007694:Killer Cells, Natural / Q000276:immunology / Q000473:pathology; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology*; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000473:pathology*; D051379:Mice; D008809:Mice, Inbred C3H; D013154:Spleen / Q000473:pathology